VANGUARD GROUP INC 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:15 pm Sale |
2023-12-29 | 13G | Twist Bioscience Corporation TWST |
VANGUARD GROUP INC | 5,475,322 9.490% |
-222,225 (-3.90%) |
Filing |
| 2023-04-10 1:39 pm Purchase |
2023-03-31 | 13G | Twist Bioscience Corporation TWST |
VANGUARD GROUP INC | 5,697,547 10.020% |
468,202 (+8.95%) |
Filing |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Twist Bioscience Corporation TWST |
VANGUARD GROUP INC | 5,229,345 9.240% |
905,737 (+20.95%) |
Filing |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Twist Bioscience Corporation TWST |
VANGUARD GROUP INC | 4,323,608 8.710% |
800,222 (+22.71%) |
Filing |
| 2021-02-10 11:57 am Purchase |
2020-12-31 | 13G | Twist Bioscience Corporation TWST |
VANGUARD GROUP INC | 3,523,386 7.310% |
3,523,386 (New Position) |
Filing |